By the advantage of targeting type II membrane proteins highly expressed in most prostate cancers, the CT value of the PC3pip tumor (PSMA-positive) was 374 HU, twice as high as that of the PC3flu tumor (PSMA-negative) site (195 HU, at 4 h p.i.). This evidence concerns the gene FOLH1 and prostate carcinoma.